TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 9.60
+0.05 (0.52%)
May 7, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 3.67 billion as of May 7, 2026. Its market cap has decreased by -63.31% in one year.
Market Cap
3.67B
Enterprise Value
3.43B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.60
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 3.67B, a decrease of -27.69%. That is a compound annual growth rate of -17.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 3.69B | -25.89% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.58B |
| Shandong Boan Biotechnology | 4.38B |
| Qyuns Therapeutics | 3.87B |
| BioDlink International Company | 3.83B |
| Clover Biopharmaceuticals | 3.75B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.50B |
| Antengene Corporation | 3.29B |